Anavex Life Sciences Corp. Share Price

Anavex Life Sciences Corp. Share Price

NASDAQ: AVXL | Micro Cap
$1.28
-$0.01 (-0.77%) Last updated on 30 Oct, 2026 | 00:03 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Anavex Life Sciences Corp. Stock Performance

Open
$1.30
Prev. Close
$1.29
Circuit Range
N/A
Day Range
$1.27 - $1.30
Year Range
$1.15 - $8.34
Volume
54,883
Average Traded
$1.29

Anavex Life Sciences Corp. Share Price Today

As of 30 October 2026, Anavex Life Sciences Corp.'s share price is $1.28. The stock opened at $1.30, compared to its previous close of $1.29. During today's trading session, Anavex Life Sciences Corp.'s share price traded between $1.27 and $1.30, with an average price of $1.29. Over the past 52 weeks, the stock has recorded a high of $8.34 and a low of $1.15. In terms of performance, Anavex Life Sciences Corp.'s share price has declined by 61.58% over the last six months and is down 83.86% on a year-on-year basis.

Anavex Life Sciences Corp. Share Price Chart

Line chart of the Anavex Life Sciences Corp. price trend over the selected period. The price fell overall, ranging from 1.27 to 1.30, ending at 1.28.
$1.27$1.30
L
Show Current Price
H

Anavex Life Sciences Corp. Stock Fundamentals & Key Indicators

Market Cap
$109.60M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.14
Revenue (TTM)
$0.00
Return On Equity (TTM)
-11.58%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
179.55%

Anavex Life Sciences Corp. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$9.83-$5.68-$5.34$7.82
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A42.22%5.99%246.44%

Anavex Life Sciences Corp. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$47.98-$47.51-$43.00-$46.38
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A0.98%9.49%-7.86%

About Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Anavex Life Sciences Corp. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.00
$1.28
-36.67%
Sep 2026
$2.79
$2.03
-35.07%
Aug 2026
$2.79
$3.13
+13.43%
Jul 2026
$2.62
$2.75
+6.58%
Jun 2026
$3.00
$2.58
-14.97%
May 2026
$3.34
$3.04
-9.12%
Apr 2026
$3.12
$3.35
+9.14%
Mar 2026
$4.48
$3.06
-30.89%
Feb 2026
$4.55
$4.43
-5.64%
Jan 2026
$3.60
$4.70
+31.65%
Dec 2025
$3.83
$3.57
-6.79%
Nov 2025
$7.89
$3.83
-51.88%

AVXL Share Price FAQs